Cancer genomes acquire somatic alterations that largely differ between and within cancer types. Several of these alterations inactivate genes that are normally functional with no deleterious consequences on cancer cells due to genetic redundancy. Here we discuss how this leads to cancer synthetic dependencies that can be exploited in therapy.
Genetic Redundancy, Functional Compensation, and Cancer Vulnerability / M. Cereda, T.P. Mourikis, F.D. Ciccarelli. - In: TRENDS IN CANCER. - ISSN 2405-8033. - 2:4(2016 Apr 04), pp. 160-162. [10.1016/j.trecan.2016.03.003]
Genetic Redundancy, Functional Compensation, and Cancer Vulnerability
M. CeredaPrimo
;
2016
Abstract
Cancer genomes acquire somatic alterations that largely differ between and within cancer types. Several of these alterations inactivate genes that are normally functional with no deleterious consequences on cancer cells due to genetic redundancy. Here we discuss how this leads to cancer synthetic dependencies that can be exploited in therapy.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
12_Trends_in_Cancer_2016.pdf
accesso riservato
Tipologia:
Publisher's version/PDF
Dimensione
533.92 kB
Formato
Adobe PDF
|
533.92 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
